Earnings calendar/MIRM
Mirum Pharmaceuticals, Inc. (MIRM)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 3, 2026
Consensus estimate row
EPS target
$-0.53
Street estimate
Revenue target
$178.1M
Street estimate
Trailing EPS (avg 4Q)
$-3.64
Beat rate last 4: 25%
Latest EPS YoY
-783.3%
vs 2025-08-06
Latest revenue YoY
+37.9%
How results look so far
Trailing revenue (avg 4Q)
$154.5M
Printed quarters
EPS beat rate (4Q)
25%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 5, 2026
EPS miss
EPS actual / est
$-1.06 / $-0.74
-42.8%
Revenue actual / est
$176.2M / $166.3M
+5.9%
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/3/2026upcoming | $-0.53 | Pending | — | $178.1M | Pending | — |
| 8/5/2026 | $-0.74 | $-1.06 | -42.8% | $166.3M | $176.2M | +5.9% |
| 7/30/2026upcoming | $-0.73 | Pending | — | $166.0M | Pending | — |
| 5/6/2026 | $-0.40 | $-13.43 | -3257.5% | $148.2M | $159.9M | +7.9% |
| 2/25/2026 | $0.02 | $-0.11 | -650.0% | $142.5M | $148.9M | +4.5% |
| 11/4/2025 | $-0.10 | $0.05 | +150.0% | $140.9M | $133.0M | -5.6% |
| 8/6/2025 | $-0.31 | $-0.12 | +61.3% | $130.1M | $127.8M | -1.8% |
| 5/7/2025 | $-0.39 | $-0.30 | +23.1% | $98.4M | $111.6M | +13.4% |
| 2/26/2025 | $-0.27 | $-0.49 | -81.5% | $96.6M | $99.4M | +2.9% |
| 11/12/2024 | $-0.45 | $-0.30 | +33.3% | $95.4M | $90.4M | -5.3% |
| 8/7/2024 | $-0.48 | $-0.52 | -8.3% | $75.3M | $77.9M | +3.5% |
| 5/8/2024 | $-0.40 | $-0.54 | -35.0% | $70.2M | $69.2M | -1.4% |
| 2/28/2024 | $-0.34 | $-0.66 | -94.1% | $67.8M | $69.6M | +2.6% |
| 11/2/2023 | $-0.64 | $-0.57 | +10.9% | $68.3M | $47.7M | -30.1% |
| 8/3/2023 | $-0.81 | $-0.92 | -13.6% | $32.5M | $37.5M | +15.5% |
| 5/4/2023 | $-0.96 | $-0.80 | +16.7% | $28.7M | $31.6M | +10.1% |
| 3/8/2023 | $-0.98 | $-0.99 | -1.0% | $24.6M | $27.9M | +13.6% |
| 11/9/2022 | $-1.05 | $-1.02 | +2.9% | $20.8M | $18.8M | -9.7% |
| 8/4/2022 | $-1.05 | $-0.84 | +20.0% | $15.4M | $17.5M | +13.4% |
| 5/5/2022 | $-1.39 | $-1.17 | +15.8% | $8.5M | $12.9M | +52.3% |
| 3/9/2022 | $-0.61 | $-0.92 | -50.8% | $62.7M | $3.1M | -95.0% |
| 11/15/2021 | $-1.63 | $-1.55 | +4.9% | $830,000 | $5.0M | +502.4% |
| 8/5/2021 | $-0.41 | $-1.45 | -253.7% | $14.5M | $11.0M | -24.1% |
| 5/6/2021 | $-0.67 | $-1.68 | -150.7% | — | Pending | — |
| 3/9/2021 | $-0.57 | $-1.43 | -150.9% | — | Pending | — |
| 11/12/2020 | $-0.99 | $-0.86 | +13.1% | — | Pending | — |
| 8/6/2020 | $-0.88 | $-0.93 | -5.7% | — | Pending | — |
| 5/7/2020 | $-0.81 | $-0.86 | -6.2% | — | Pending | — |
| 3/12/2020 | $-0.85 | $-0.79 | +7.1% | — | Pending | — |
| 11/6/2019 | $-0.52 | $-0.84 | -61.5% | — | Pending | — |
| 8/28/2019 | $-0.57 | $-5.31 | -831.6% | — | Pending | — |
| 7/25/2019 | — | $-0.60 | — | — | Pending | — |
| 12/31/2018 | — | $-9.52 | — | — | Pending | — |
| 9/30/2018 | — | $-0.01 | — | — | Pending | — |